Browse U.S. drug recall enforcement reports from the FDA in a structured, searchable format. Review the recalled product, reason, firm, status, dates, distribution information and FDA classification when available.
10,685 detailed records are currently available in this category.
Chemical contamination: product contains elevated levels of undeclared lead.
cGMP deviations
Chemical contamination: product contains elevated levels of undeclared lead.
Chemical contamination: product contains elevated levels of undeclared lead.
Chemical contamination: product contains elevated levels of undeclared lead.
Lack of Assurance of Sterility; potential loose metal overseal crimp defects.
Chemical contamination: product contains elevated levels of undeclared lead.
Chemical contamination: product contains elevated levels of undeclared lead.
Chemical contamination: product contains elevated levels of undeclared lead.
Chemical contamination: product contains elevated levels of undeclared lead.
Chemical contamination: product contains elevated levels of undeclared lead.
Chemical contamination: product contains elevated levels of undeclared lead.
Microbial contamination of non-sterile products: positive microbial contamination in product.
Chemical contamination: product contains elevated levels of undeclared lead.
Chemical contamination: product contains elevated levels of undeclared lead.
Lack of Processing Controls (lack of assurance of conformity to specifications).
Presence of Foreign Tablets/Capsules: Lisinopril Tablets USP, 20mg found in a 1000 count bottle of Lisinopril Tablets USP, 10mg
SUBPOTENT DRUG: Products failed assay results at the 12 and 24 month timepoints.
Cross contamination with other products - OOS discovered during routine stability testing for highest unknown impurity later identified as clozapine
Chemical Contamination: Product contains undeclared methanol.
CGMP Deviations: Product was found to be below the label claim for ethanol content and the presence of undeclared methanol.
Incorrect/Undeclared Excipients: Notification received from Health Canada that DA-2I Ethanol is a type not an approved for use in Hand Sanitizer.
Superpotent Drug: Out-of-specification (OOS) result observed in an assay test of retention samples.
TEMPERATURE ABUSE: Complaint received from customer that product was received in a non-refrigerated state.
A drug recall record can include the reason for recall, firm, status, distribution pattern, quantity and FDA classification. This site does not provide medical advice; it organizes public recall information and links users back to official sources.
Recall Lookup USA keeps the last complete source record available when an official data service is temporarily unavailable. When a source provides only a few fields, we show only those known facts rather than padding the page with generic text.
This database is designed for discovery and reference. It can help you locate a relevant recall record, identify the recalling firm or NHTSA campaign, compare dates and classifications, and follow the official source. It is not a substitute for a VIN-specific NHTSA check, a manufacturer notice, medical advice or instructions issued by the recalling company.
